PATENT CLAIM ANALYSIS

Application Number: 15910206
Application Type: Utility
Filing Date: 2018-03
Publication Date: 2018-09
Patent Classification: ["424", "146100"]

Abstract:
A monoclonal antibody that binds to a phospholipase D4 (PLD4) protein, or a fragment containing an antigen-binding region thereof.

Claim (Index 44):
A method for suppressing an activity of a plasmacytoid dendritic cell in a living organism, comprising administering to the living organism an antibody, or antigen-binding fragment thereof, that binds to human phospholipase D4 (PLD4) protein on the plasmacytoid dendritic cell and suppresses the activity of the plasmacytoid dendritic cell, wherein the activity of the plasmacytoid dendritic cell is production of interferon, survival, or production of interferon and survival.

Metadata:
- Claim Count in Document: 8.0
- Percentile: 90.0
- Lexical Diversity: 1.04545
- Patent Class: 424.0
- Transitional Phrase Type: open
- Component Type: 1
- Foreign Priority: True
- Related Applications: ['14375266', '14113904', '14649297', '14360694', '14257480']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.6914495077885114
- 35 USC 102 Novelty (BERT): 0.5854167654482425
- Combined Prediction Score: 0.6808462335544846
- Mean Citation Score: 353.882578
- Max Citation Score: 573.5748
- Similarity Product: 369.06723034751417

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 0
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test